Cardiovascular Research Institute Düsseldorf

Offizieller Account des 2013 gegründeten Forschungsverbundes CARID - Cardiovascular Research Institute Düsseldorf. Header ©Universitätsklinikum Düsseldorf

[Cardiovascular Research Institute Düsseldorf @CARIDHHU]

CARID schließt sich der HHU an und verlässt X. Infos rund um CARID finden Sie natürlich weiterhin auf den anderen Kanälen: @caridhuu
#bsky.social #instagram #facebook

[Heinrich-Heine-Universität Düsseldorf @HHU_de]

Zeit, neue Wege zu gehen: Wir beenden unsere Aktivitäten auf X. Bleibt mit uns im Dialog – auf unseren anderen Kanälen.
#eXit #WissXit #ByeByeX #QuitX
https://t.co/1PLB2hZhYh

[Intensive Care Medicine @yourICM]

Using routinely collected #ICU data?
#AI models may assist in diagnosis, treatment & complex care, but before using for #datascience several challenges: quality, lacking long term outcomes, inherent bias, need for temporal updates, should be considered.
🔗 https://t.co/xeYCWhnvit

[Holger Thiele @thiele_holger]

Just published: AI analysis ECLS-SHOCK trial https://t.co/ggykMxWx8x ⁦@JACCJournals⁩ ⁦@AnneFreund3⁩ ⁦@JaninePoss⁩ ⁦@KP_Kresoja⁩ ⁦@CHassager⁩ ⁦@NavinKapur4⁩ ⁦@DGK_AG3⁩

[JTH @JTHjournal]

Long-term FXa inhibition induces anti-thromboinflammatory proteome signatures in platelets, improving infarct size after myocardial infarction and stroke.

https://t.co/ityqlkNlvp

[Uniklinik Düsseldorf @UniklinikDUS]

6. Arzt-Patienten-VAD-HTX-Seminar: Rund 170 Teilnehmende diskutierten an der Uniklinik #Düsseldorf kürzlich über neue medizinische Entwicklungen, über #Organspendezahlen und über die Gesetzesinitiative für die Einführung einer #Widerspruchslösung. https://t.co/Zx0HIkJWko

[DGG-Gefäßchirurgie @DGG_Tweets]

Die DGG hat im Rahmen ihrer 40. Jahrestagung herausragende wissenschaftliche Arbeiten geehrt.
Herzlichen Glückwunsch an die Preisträgerinnen und Preisträger:

🏅 Aortenpreis:
Prof. Dr. med. Markus Wagenhäuser (Düsseldorf) für sein Projekt „Crosstalk of platelets with macrophages and fibroblasts aggravates inflammation, aortic wall stiffening, and osteopontin release in abdominal aortic aneurysm“.

🔬 Wissenschaftspreis:
Dr. med. Joscha Mulorz (Düsseldorf) für sein Projekt „E-cigarette exposure augments murine abdominal aortic aneurysm development: role of Chil1“.

🎓 Promotionsstipendium:
Cathryn Bassett (Aachen) für ihr Projekt „Die Rolle intramuraler Matrixmetaloproteasen 2 und 9 im Kontext degenerativer Wandumbauprozesse in thorakoabdominellen Aortenaneurysmen bei Marfan- und Non-Marfan-Patient:innen“.

[INDICATE @INDICATE_EUROPE]

🇪🇺The INDICATE project has officially launched!🚀

This European initiative aims to improve data sharing between ICUs, advance patient-centered care, and develop trustworthy #AI models through ethically responsible data use.🤝

Read more via: https://t.co/AJkU30YScX

[EHJACVC Editor-in-Chief @EHJACVCEiC]

When macrocirculation is not enough we call for help microcirculation - just published paper at #EHJACVC on the role of microcirculation in management of #Cardshock by @cjungMD https://t.co/4nbllvkxw0

@ESC_Journals @escardio @ann_oleksiak @drmilicaa @maria_bergami @ACVCPresident @FH_Verbrugge @rafavidalperez @JasonKatzMD @seanvandiepen @franciscojlk

[Amin Polzin @amin_polzin]

I'm very happy to present another research paper from our group.

https://t.co/J36pQYv8Aj

#herzklappe #valve #valvedisease #cardiology #research #clinical #clinicalresearch #sphingosine1phosphate #stenosis #signaling #circulacion #heart #heartdisease

[Abdulla A. Damluji, MD, PhD @DrDamluji]

Microaxial Flow Pump Use and Renal Outcomes in Infarct-Related Cardiogenic Shock – a Secondary Analysis of the DanGer Shock Trial: @CircAHA

🥸 Good morning

😱 Few summary points from this sub-analysis from DanGer Shock

👇👇👇

[Elric Zweck @ElricZweck]

Out now in @CircAHA: an in-depth analysis of #renal risk factors and outcomes in the #DanGer #shock trial. Led by pioneer #JacobEMoller. Accompanied by an excellent editorial by @SarasVallabhMD.
@CHassager @RalfWestenfeld @amin_polzin
https://t.co/rd5C8iUUa7

[Miriam Cortese-Krott @miriamcortese]

🚨 Excited to share our latest publication in Pharmacological Reviews!

Thank @heuser_k and @Junjie_L0616 and all coauthors @KrottLab for their invaluable contributions!

🔗 Read more: https://t.co/GgNQYDN2aq

#Pharmacology #Arginase #Immunology #CancerTherapeutics #Research

[Christian Jung @cjungMD]

Our just published #Bayesian analysis 📊 of the CULPRIT-Shock 😱 trial generates further evidence favoring the culprit-lesion-only PCI strategy in AMI ♥️patients with cardiogenic #SHOCK and multivessel disease. Link: https://t.co/yzoHX1qtdQ 📒@thiele_holger @BernhardWernly

[Anja Steinbeck @anja_steinbeck]

Ein RIESENERFOLG war die Nacht der Wissenschaft mit 14.000 Besuchern. Mein großer Dank geht an alle Wissenschaftler*innen, die den ganzen Abend ihre Forschung erklärt haben, bis sie heiser waren.

https://t.co/gJ683LnHaF

[Konstantin Krychtiuk @krychtiukmd]

Happy and proud to share our international, state-of-the-art review on the management of cardiogenic shock in @yourICM

Great leadership by @cjungMD bringing together the ideas and opinions of a truly international and global writing group.

https://t.co/4nrBaXbSTn

[TRR259 @trr259]

As the first day of the #TRR259 retreat at the beautiful Seehotel Maria Laach comes to a close, we’ve had inspiring discussions, great progress, and even a fascinating tour of the Maria Laach Abbey. 🌅💡 Looking forward to more tomorrow! #Research #Teamwork @WinkelsLab

[Kevin John John, MD MRCP @drkevinjj]

'SCAI-walking' patient trajectories shows why stage B is Bad! Congratulations to @tonkhueMdPhd @ElricZweck @NavinKapur4 @manreetkanwar @JHMontfort10 @lisong2003 and team for this effort! https://t.co/vKd0x7dCIV
Check out the CSWG-SCAI Walker app to 'SCAI-walk' your patients!

[Amin Polzin @amin_polzin]

Dr. rer. nat. Benkhoff had the opportunity to give a presentation on "S1P reduces arterial thrombosis via endothelial thrombomodulin expression by S1PR1 signaling" at the #esc2024 and was able to discuss our research group’s findings. We returned with many impressions and ideas!

[Intensive Care Medicine @yourICM]

#ECLS in AMICS
⚖️ Bayesian analysis of ECLS-SHOCK
⚠️ large benefit of routine use of #ECMO on mortality likely nil; with high risk of bleeding/vascular complications, cautiously balance (unlikely) potential benefits vs (very likely) adverse outcomes risk
🔓https://t.co/YYtbGOqgkf

[Philipp Mourikis @ph_mourikis]

New insights into S1P regulating arterial thrombosis from @amin_polzin working group at #ESCCongress2024 #ESC2024 @escardio @DGK_org @YoungDgk @HHU_de @UniklinikDUS